These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27708548)

  • 1. KIAA0101, a target gene of miR-429, enhances migration and chemoresistance of epithelial ovarian cancer cells.
    Chen H; Xia B; Liu T; Lin M; Lou G
    Cancer Cell Int; 2016; 16():74. PubMed ID: 27708548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A7 Regulates Ovarian Cancer Cell Metastasis and Chemoresistance Through MAPK Signaling and Is Targeted by miR-330-5p.
    Lin M; Xia B; Qin L; Chen H; Lou G
    DNA Cell Biol; 2018 May; 37(5):491-500. PubMed ID: 29485916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
    Zhang Y; Dun Y; Zhou S; Huang XH
    Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
    Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
    Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
    Zhuang XH; Liu Y; Li JL
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer.
    Zhang Y; Zhao FJ; Chen LL; Wang LQ; Nephew KP; Wu YL; Zhang S
    Oncotarget; 2014 Dec; 5(23):12291-303. PubMed ID: 25460499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression.
    Zhang J; Liu L; Sun Y; Xiang J; Zhou D; Wang L; Xu H; Yang X; Du N; Zhang M; Yan Q; Xi X
    Oncotarget; 2016 May; 7(18):26516-34. PubMed ID: 27049921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome Component 4 Promotes Epithelial Ovarian Cancer Cell Proliferation, Migration, and Invasion
    Xiong C; Sun Z; Yu J; Lin Y
    Front Oncol; 2021; 11():797968. PubMed ID: 34956910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-539-3p promotes the progression of epithelial ovarian cancer by targeting SPARCL1.
    Gong YB; Fan XH
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2366-2373. PubMed ID: 30964161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-27a promotes EMT in ovarian cancer through active Wnt/𝜷-catenin signalling by targeting FOXO1.
    Zhang LY; Chen Y; Jia J; Zhu X; He Y; Wu LM
    Cancer Biomark; 2019; 24(1):31-42. PubMed ID: 30614794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-130b functions as a tumor suppressor by regulating RUNX3 in epithelial ovarian cancer.
    Paudel D; Zhou W; Ouyang Y; Dong S; Huang Q; Giri R; Wang J; Tong X
    Gene; 2016 Jul; 586(1):48-55. PubMed ID: 27048832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The suppressive role of miR-362-3p in epithelial ovarian cancer.
    Yuan J; Li T; Yi K; Hou M
    Heliyon; 2020 Jul; 6(7):e04258. PubMed ID: 32671239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-381 inhibits epithelial ovarian cancer malignancy via YY1 suppression.
    Xia B; Li H; Yang S; Liu T; Lou G
    Tumour Biol; 2016 Jul; 37(7):9157-67. PubMed ID: 26768613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-206 as a prognostic and sensitivity biomarker for platinum chemotherapy in epithelial ovarian cancer.
    Yu X; Zhang X; Wang G; Wang B; Ding Y; Zhao J; Liu H; Cui S
    Cancer Cell Int; 2020 Nov; 20(1):534. PubMed ID: 33292230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-936 targets FGF2 to inhibit epithelial ovarian cancer aggressiveness by deactivating the PI3K/Akt pathway.
    Li C; Yu S; Wu S; Ni Y; Pan Z
    Onco Targets Ther; 2019; 12():5311-5322. PubMed ID: 31371979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-153 regulated AKT1 expression and suppressed cell proliferation of epithelial ovarian cancer cells.
    Li W; Wang M; Meng B; Yu J; Chen Q; Li H; Liu Y
    Int J Clin Exp Pathol; 2017; 10(7):7417-7426. PubMed ID: 31966584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-205 promotes motility of ovarian cancer cells via targeting ZEB1.
    Niu K; Shen W; Zhang Y; Zhao Y; Lu Y
    Gene; 2015 Dec; 574(2):330-6. PubMed ID: 26275944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
    Xia B; Yang S; Liu T; Lou G
    Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA-574-3p inhibits metastasis and chemoresistance of epithelial ovarian cancer (EOC) by negatively regulating epidermal growth factor receptor (EGFR).
    Zhang P; Zhu J; Zheng Y; Zhang H; Sun H; Gao S
    Am J Transl Res; 2019; 11(7):4151-4165. PubMed ID: 31396325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. USP43 impairs cisplatin sensitivity in epithelial ovarian cancer through HDAC2-dependent regulation of Wnt/β-catenin signaling pathway.
    Pei L; Zhao F; Zhang Y
    Apoptosis; 2024 Feb; 29(1-2):210-228. PubMed ID: 38087046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.